Page last updated: 2024-09-05

loureirin b and Osteoporosis

loureirin b has been researched along with Osteoporosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, K; Chen, L; Chen, Z; Deng, Z; He, W; Kenny, J; Liu, Y; Song, D; Sun, Y; Tickner, J; Wang, C; Wang, G; Wang, H; Xu, J; Zhang, Q; Zhou, C	1

Other Studies

1 other study(ies) available for loureirin b and Osteoporosis

Article	Year
Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities. Theranostics, 2019, Volume: 9, Issue:16 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bone Resorption; Cell Differentiation; Cell Proliferation; Durapatite; Female; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteoporosis; Ovariectomy; RANK Ligand; Reactive Oxygen Species; Resins, Plant	2019

Article

Year

Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities.

Theranostics, 2019, Volume: 9, Issue:16

Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bone Resorption; Cell Differentiation; Cell Proliferation; Durapatite; Female; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteoporosis; Ovariectomy; RANK Ligand; Reactive Oxygen Species; Resins, Plant

2019